Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Neoplasms

Explore clinical trials studying Gastrointestinal Neoplasms. Study availability and eligibility vary by location and protocol.

9,258 public trials 2,060 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Neoplasms trial results

Completed

IBD Neoplasia Surveillance Pilot RCT

NCT04067778

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +11 more
Locations
  • University of Alberta Edmonton, Alberta, Canada
  • St. Paul's Hospital Vancouver, British Columbia, Canada
  • Pacific Digestive Health / Royal Jubilee Hospital Victoria, British Columbia, Canada
  • University of Manitoba, Health Sciences Centre Winnipeg, Manitoba, Canada
View Trial Details
Completed

A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

NCT03849469

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced or Metastatic Solid Tumors, +108 more
Locations
  • UCSD Medical Center - Encinitas Encinitas, California, United States
  • Koman Family Outpatient Pavilion La Jolla, California, United States
  • UC San Diego Medical Center - La Jolla (Jacobs Medical Center / Thornton Pavilion) La Jolla, California, United States
  • UCSD Altman Clinical and Translational Research Institute Building (ACTRI) La Jolla, California, United States
View all 28 locations
View Trial Details
Completed

Study of Pembrolizumab (MK-3475) Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal/Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)-China Extension Study

NCT03933449

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Carcinoma, +9 more
Locations
  • Anhui Provincial Hospital ( Site 0708) Hefei, Anhui, China
  • The First Affiliated Hospital of Anhui Medical University ( Site 0707) Hefei, Anhui, China
  • Harbin Medical University Cancer Hospital ( Site 0714) Harbin, Heilongjiang, China
  • Wuhan Tongji Hospital ( Site 0724) Wuhan, Hubei, China
View all 23 locations
View Trial Details
Completed

Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST

NCT02638766

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +10 more
Locations
  • Institute Bergonie Bordeaux, France
  • Centre Leon Berard Lyon, France
  • Gustave Roussy Villejuif, France
  • Fondazione IRCCS Istituto Dei Tumori di Milano Milan, Italy
View all 17 locations
View Trial Details

Related conditions